These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


371 related items for PubMed ID: 33213556

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders.
    Vanegas-Arroyave N, Caroff SN, Citrome L, Crasta J, McIntyre RS, Meyer JM, Patel A, Smith JM, Farahmand K, Manahan R, Lundt L, Cicero SA.
    CNS Drugs; 2024 Apr; 38(4):239-254. PubMed ID: 38502289
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy.
    Musco S, Ruekert L, Myers J, Anderson D, Welling M, Cunningham EA.
    J Clin Psychopharmacol; 2019 Apr; 39(4):336-343. PubMed ID: 31205194
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS, Sauvanaud F, Limosin F.
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tardive syndrome: An update and mini-review from the perspective of phenomenology.
    Chen CY, Chiang HL, Fuh JL.
    J Chin Med Assoc; 2020 Dec; 83(12):1059-1065. PubMed ID: 32956105
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical management of tardive dyskinesia: Five steps to success.
    Citrome L.
    J Neurol Sci; 2017 Dec 15; 383():199-204. PubMed ID: 29246613
    [Abstract] [Full Text] [Related]

  • 16. Tardive dyskinesia: Who gets it and why.
    Frei K.
    Parkinsonism Relat Disord; 2019 Feb 15; 59():151-154. PubMed ID: 30522959
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment tool.
    Bhidayasiri R, Kane JM, Frei KP, Caroff SN, Correll CU, Fahn S, Jankovic J, Hauser RA, Truong DD.
    Parkinsonism Relat Disord; 2020 Aug 15; 77():141-145. PubMed ID: 32823151
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.